Lemonade (NYSE:LMND) Director Debra Schwartz Sells 4,200 Shares

Lemonade, Inc. (NYSE:LMND) Director Debra Schwartz sold 4,200 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $83.59, for a total transaction of $351,078.00. Following the transaction, the director directly owned 21,567 shares in the company, valued at approximately $1,802,785.53. The trade was a 16.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Lemonade Trading Down 3.5%

LMND opened at $75.16 on Tuesday. Lemonade, Inc. has a twelve month low of $24.31 and a twelve month high of $84.52. The firm has a market cap of $5.62 billion, a price-to-earnings ratio of -31.45 and a beta of 2.13. The company has a fifty day simple moving average of $66.10 and a 200 day simple moving average of $53.72.

Lemonade (NYSE:LMND) last announced its earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.21. Lemonade had a negative return on equity of 31.86% and a negative net margin of 26.39%.The company had revenue of $194.50 million during the quarter, compared to the consensus estimate of $185.06 million. During the same period last year, the firm earned ($0.95) earnings per share. The company’s revenue was up 42.4% on a year-over-year basis. On average, analysts forecast that Lemonade, Inc. will post -3.03 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Morgan Stanley increased their target price on Lemonade from $49.00 to $53.00 and gave the company an “underweight” rating in a research note on Monday, November 17th. Keefe, Bruyette & Woods raised their price objective on shares of Lemonade from $35.00 to $40.00 and gave the stock an “underperform” rating in a report on Tuesday, November 25th. Citigroup reissued a “market outperform” rating on shares of Lemonade in a research report on Monday, November 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Lemonade in a research note on Wednesday, October 8th. Finally, BMO Capital Markets upped their price objective on Lemonade from $23.00 to $42.00 and gave the company an “underperform” rating in a research note on Monday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Lemonade currently has a consensus rating of “Hold” and an average target price of $58.57.

Institutional Investors Weigh In On Lemonade

A number of hedge funds have recently made changes to their positions in the business. Strategic Advocates LLC bought a new position in Lemonade in the 3rd quarter worth approximately $33,000. CIBC Bancorp USA Inc. acquired a new position in Lemonade during the 3rd quarter worth $318,000. Advisory Services Network LLC bought a new position in shares of Lemonade in the third quarter worth $216,000. CANADA LIFE ASSURANCE Co increased its holdings in shares of Lemonade by 11.6% during the third quarter. CANADA LIFE ASSURANCE Co now owns 17,769 shares of the company’s stock valued at $966,000 after purchasing an additional 1,844 shares during the period. Finally, Worth Venture Partners LLC bought a new stake in shares of Lemonade during the third quarter valued at about $297,000. Institutional investors own 80.30% of the company’s stock.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.